 | • レポートコード：GIR-107A11924 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、梅毒診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。梅毒診断の種類別市場規模（ゲル微小液滴、イムノアッセイ、分子診断、その他）、用途別市場規模（病院、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・梅毒診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Danaher、Novartis、Thermo Fisher、Roche、Bio-Rad、BioMerieux、American Standard、Eiken Chemical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ゲル微小液滴、イムノアッセイ、分子診断、その他 ・用途別分析2016年-2026年：病院、診断センター、その他 ・梅毒診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・梅毒診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・梅毒診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・梅毒診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・梅毒診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Syphilis Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Syphilis Diagnosis size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Syphilis Diagnosis market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Syphilis Diagnosis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gel Micro-droplets
Immunoassays
Molecular Diagnostics
Others
Market segment by Application, can be divided into
Hospital
Dagnostics Center
Others
Market segment by players, this report covers
Abbott
Danaher
Novartis
Thermo Fisher
Roche
Bio-Rad
BioMerieux
American Standard
Eiken Chemical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Syphilis Diagnosis
1.2 Classification of Syphilis Diagnosis by Type
1.2.1 Overview: Global Syphilis Diagnosis Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Syphilis Diagnosis Revenue Market Share by Type in 2020
1.2.3 Gel Micro-droplets
1.2.4 Immunoassays
1.2.5 Molecular Diagnostics
1.2.6 Others
1.3 Global Syphilis Diagnosis Market by Application
1.3.1 Overview: Global Syphilis Diagnosis Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Dagnostics Center
1.3.4 Others
1.4 Global Syphilis Diagnosis Market Size & Forecast
1.5 Global Syphilis Diagnosis Market Size and Forecast by Region
1.5.1 Global Syphilis Diagnosis Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Syphilis Diagnosis Market Size by Region, (2016-2021)
1.5.3 North America Syphilis Diagnosis Market Size and Prospect (2016-2026)
1.5.4 Europe Syphilis Diagnosis Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Syphilis Diagnosis Market Size and Prospect (2016-2026)
1.5.6 South America Syphilis Diagnosis Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Syphilis Diagnosis Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Syphilis Diagnosis Market Drivers
1.6.2 Syphilis Diagnosis Market Restraints
1.6.3 Syphilis Diagnosis Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Syphilis Diagnosis Product and Solutions
2.1.4 Abbott Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Syphilis Diagnosis Product and Solutions
2.2.4 Danaher Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Syphilis Diagnosis Product and Solutions
2.3.4 Novartis Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Thermo Fisher
2.4.1 Thermo Fisher Details
2.4.2 Thermo Fisher Major Business
2.4.3 Thermo Fisher Syphilis Diagnosis Product and Solutions
2.4.4 Thermo Fisher Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Syphilis Diagnosis Product and Solutions
2.5.4 Roche Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business
2.6.3 Bio-Rad Syphilis Diagnosis Product and Solutions
2.6.4 Bio-Rad Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bio-Rad Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Syphilis Diagnosis Product and Solutions
2.7.4 BioMerieux Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 American Standard
2.8.1 American Standard Details
2.8.2 American Standard Major Business
2.8.3 American Standard Syphilis Diagnosis Product and Solutions
2.8.4 American Standard Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 American Standard Recent Developments and Future Plans
2.9 Eiken Chemical
2.9.1 Eiken Chemical Details
2.9.2 Eiken Chemical Major Business
2.9.3 Eiken Chemical Syphilis Diagnosis Product and Solutions
2.9.4 Eiken Chemical Syphilis Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Eiken Chemical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Syphilis Diagnosis Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Syphilis Diagnosis Players Market Share
3.2.2 Top 10 Syphilis Diagnosis Players Market Share
3.2.3 Market Competition Trend
3.3 Syphilis Diagnosis Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Syphilis Diagnosis Revenue and Market Share by Type (2016-2021)
4.2 Global Syphilis Diagnosis Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Syphilis Diagnosis Revenue Market Share by Application (2016-2021)
5.2 Syphilis Diagnosis Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Syphilis Diagnosis Revenue by Type (2016-2026)
6.2 North America Syphilis Diagnosis Revenue by Application (2016-2026)
6.3 North America Syphilis Diagnosis Market Size by Country
6.3.1 North America Syphilis Diagnosis Revenue by Country (2016-2026)
6.3.2 United States Syphilis Diagnosis Market Size and Forecast (2016-2026)
6.3.3 Canada Syphilis Diagnosis Market Size and Forecast (2016-2026)
6.3.4 Mexico Syphilis Diagnosis Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Syphilis Diagnosis Revenue by Type (2016-2026)
7.2 Europe Syphilis Diagnosis Revenue by Application (2016-2026)
7.3 Europe Syphilis Diagnosis Market Size by Country
7.3.1 Europe Syphilis Diagnosis Revenue by Country (2016-2026)
7.3.2 Germany Syphilis Diagnosis Market Size and Forecast (2016-2026)
7.3.3 France Syphilis Diagnosis Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Syphilis Diagnosis Market Size and Forecast (2016-2026)
7.3.5 Russia Syphilis Diagnosis Market Size and Forecast (2016-2026)
7.3.6 Italy Syphilis Diagnosis Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Syphilis Diagnosis Revenue by Type (2016-2026)
8.2 Asia-Pacific Syphilis Diagnosis Revenue by Application (2016-2026)
8.3 Asia-Pacific Syphilis Diagnosis Market Size by Region
8.3.1 Asia-Pacific Syphilis Diagnosis Revenue by Region (2016-2026)
8.3.2 China Syphilis Diagnosis Market Size and Forecast (2016-2026)
8.3.3 Japan Syphilis Diagnosis Market Size and Forecast (2016-2026)
8.3.4 South Korea Syphilis Diagnosis Market Size and Forecast (2016-2026)
8.3.5 India Syphilis Diagnosis Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Syphilis Diagnosis Market Size and Forecast (2016-2026)
8.3.7 Australia Syphilis Diagnosis Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Syphilis Diagnosis Revenue by Type (2016-2026)
9.2 South America Syphilis Diagnosis Revenue by Application (2016-2026)
9.3 South America Syphilis Diagnosis Market Size by Country
9.3.1 South America Syphilis Diagnosis Revenue by Country (2016-2026)
9.3.2 Brazil Syphilis Diagnosis Market Size and Forecast (2016-2026)
9.3.3 Argentina Syphilis Diagnosis Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Syphilis Diagnosis Revenue by Type (2016-2026)
10.2 Middle East & Africa Syphilis Diagnosis Revenue by Application (2016-2026)
10.3 Middle East & Africa Syphilis Diagnosis Market Size by Country
10.3.1 Middle East & Africa Syphilis Diagnosis Revenue by Country (2016-2026)
10.3.2 Turkey Syphilis Diagnosis Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Syphilis Diagnosis Market Size and Forecast (2016-2026)
10.3.4 UAE Syphilis Diagnosis Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Syphilis Diagnosis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Syphilis Diagnosis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Syphilis Diagnosis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Syphilis Diagnosis Revenue (USD Million) by Region (2016-2021)
Table 5. Global Syphilis Diagnosis Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Syphilis Diagnosis Product and Solutions
Table 9. Abbott Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Danaher Corporate Information, Head Office, and Major Competitors
Table 11. Danaher Major Business
Table 12. Danaher Syphilis Diagnosis Product and Solutions
Table 13. Danaher Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Syphilis Diagnosis Product and Solutions
Table 17. Novartis Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Major Business
Table 20. Thermo Fisher Syphilis Diagnosis Product and Solutions
Table 21. Thermo Fisher Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Syphilis Diagnosis Product and Solutions
Table 25. Roche Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Major Business
Table 28. Bio-Rad Syphilis Diagnosis Product and Solutions
Table 29. Bio-Rad Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 31. BioMerieux Major Business
Table 32. BioMerieux Syphilis Diagnosis Product and Solutions
Table 33. BioMerieux Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. American Standard Corporate Information, Head Office, and Major Competitors
Table 35. American Standard Major Business
Table 36. American Standard Syphilis Diagnosis Product and Solutions
Table 37. American Standard Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Eiken Chemical Corporate Information, Head Office, and Major Competitors
Table 39. Eiken Chemical Major Business
Table 40. Eiken Chemical Syphilis Diagnosis Product and Solutions
Table 41. Eiken Chemical Syphilis Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Syphilis Diagnosis Revenue (USD Million) by Players (2019-2021)
Table 43. Global Syphilis Diagnosis Revenue Share by Players (2019-2021)
Table 44. Breakdown of Syphilis Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Syphilis Diagnosis Players Head Office, Products and Services Provided
Table 46. Syphilis Diagnosis Mergers & Acquisitions in the Past Five Years
Table 47. Syphilis Diagnosis New Entrants and Expansion Plans
Table 48. Global Syphilis Diagnosis Revenue (USD Million) by Type (2016-2021)
Table 49. Global Syphilis Diagnosis Revenue Share by Type (2016-2021)
Table 50. Global Syphilis Diagnosis Revenue Forecast by Type (2021-2026)
Table 51. Global Syphilis Diagnosis Revenue by Application (2016-2021)
Table 52. Global Syphilis Diagnosis Revenue Forecast by Application (2021-2026)
Table 53. North America Syphilis Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Syphilis Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Syphilis Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Syphilis Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Syphilis Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Syphilis Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Syphilis Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Syphilis Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Syphilis Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Syphilis Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Syphilis Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Syphilis Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Syphilis Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Syphilis Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Syphilis Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Syphilis Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Syphilis Diagnosis Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Syphilis Diagnosis Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Syphilis Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Syphilis Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Syphilis Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Syphilis Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Syphilis Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Syphilis Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Syphilis Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Syphilis Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Syphilis Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Syphilis Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Syphilis Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Syphilis Diagnosis Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Syphilis Diagnosis Picture
Figure 2. Global Syphilis Diagnosis Revenue Market Share by Type in 2020
Figure 3. Gel Micro-droplets
Figure 4. Immunoassays
Figure 5. Molecular Diagnostics
Figure 6. Others
Figure 7. Syphilis Diagnosis Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Dagnostics Center Picture
Figure 10. Others Picture
Figure 11. Global Syphilis Diagnosis Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Syphilis Diagnosis Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Syphilis Diagnosis Revenue Market Share by Region (2016-2026)
Figure 14. Global Syphilis Diagnosis Revenue Market Share by Region in 2020
Figure 15. North America Syphilis Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Syphilis Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Syphilis Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Syphilis Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Syphilis Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Syphilis Diagnosis Market Drivers
Figure 21. Syphilis Diagnosis Market Restraints
Figure 22. Syphilis Diagnosis Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Danaher Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Thermo Fisher Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Bio-Rad Recent Developments and Future Plans
Figure 29. BioMerieux Recent Developments and Future Plans
Figure 30. American Standard Recent Developments and Future Plans
Figure 31. Eiken Chemical Recent Developments and Future Plans
Figure 32. Global Syphilis Diagnosis Revenue Share by Players in 2020
Figure 33. Syphilis Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Syphilis Diagnosis Revenue Market Share in 2020
Figure 35. Global Top 10 Players Syphilis Diagnosis Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Syphilis Diagnosis Revenue Share by Type in 2020
Figure 38. Global Syphilis Diagnosis Market Share Forecast by Type (2021-2026)
Figure 39. Global Syphilis Diagnosis Revenue Share by Application in 2020
Figure 40. Global Syphilis Diagnosis Market Share Forecast by Application (2021-2026)
Figure 41. North America Syphilis Diagnosis Sales Market Share by Type (2016-2026)
Figure 42. North America Syphilis Diagnosis Sales Market Share by Application (2016-2026)
Figure 43. North America Syphilis Diagnosis Revenue Market Share by Country (2016-2026)
Figure 44. United States Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Syphilis Diagnosis Sales Market Share by Type (2016-2026)
Figure 48. Europe Syphilis Diagnosis Sales Market Share by Application (2016-2026)
Figure 49. Europe Syphilis Diagnosis Revenue Market Share by Country (2016-2026)
Figure 50. Germany Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Syphilis Diagnosis Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Syphilis Diagnosis Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Syphilis Diagnosis Revenue Market Share by Region (2016-2026)
Figure 58. China Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Syphilis Diagnosis Sales Market Share by Type (2016-2026)
Figure 65. South America Syphilis Diagnosis Sales Market Share by Application (2016-2026)
Figure 66. South America Syphilis Diagnosis Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Syphilis Diagnosis Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Syphilis Diagnosis Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Syphilis Diagnosis Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Syphilis Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
分子診断（MDx）の世界市場 2019年版：種類別（非侵襲的出生前検査（NIPT）、診断とともに、液体生検、その他の分子診断）、用途別（心血管、神経学、胃腸病学、感染症、腫瘍学、その他） Scope of the Report: The global Molecular Diagnosis (MDx) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,…- 世界の非侵襲的がん診断市場 2021：企業別、地域別、種類・用途別 The Non-invasive Cancer Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の顧みられない熱帯病診断市場 2021：企業別、地域別、種類・用途別 The Neglected Tropical Diseases Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のカポジ肉腫診断市場 2021：企業別、地域別、種類・用途別 The Kaposi Sarcoma Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の鎌状赤血球症診断市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Sickle Cell Disease Diagnosis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…